Axonal degeneration and inflammation in acute optic neuritis
Open Access
- 1 August 2004
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 75 (8) , 1178-1180
- https://doi.org/10.1136/jnnp.2003.017236
Abstract
Aims: To investigate whether plasma biomarkers for axonal injury and inflammation are related to loss and recovery of visual function in acute optic neuritis (ON). Methods: Eighteen patients with ON and 14 controls were investigated in a longitudinal, prospective study. Plasma phosphorylated neurofilament heavy chain (NfHSMI35; a surrogate marker of axonal injury), nitric oxide metabolites (NOx), and citrulline (surrogate markers of inflammation) were measured. Results: Patients with ON had higher median plasma NfHSMI35 values than controls (0.17 versus 0.005 ng/ml; p < 0.05) and higher NOx values (49 versus 35.5μM; p < 0.001). Plasma NfHSMI35 values correlated inversely with visual acuity at presentation (R = −0.67; p = 0.01). NfHSMI35 was higher in patients with poor recovery of visual acuity than in those with good recovery (0.25 ng/ml versus 0.09 ng/ml; p < 0.05). Three of four patients with high NfHSMI35 and high NOx values experienced a poor recovery as opposed to only one of five with high NOx but normal NfHSMI35 values. Conclusions: NfHSMI35, a surrogate marker for axonal damage, is a prognostic indicator and should be considered in the design of neuroprotective treatment strategies.Keywords
This publication has 25 references indexed in Scilit:
- Corticosteroids do not prevent optic nerve atrophy following optic neuritisJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Nitric oxide and the axonal death cascadeAnnals of Neurology, 2003
- Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degenerationAnnals of Neurology, 2002
- Management of acute optic neuritisThe Lancet, 2002
- Continuing optic nerve atrophy following optic neuritis: a serial MRI studyMultiple Sclerosis Journal, 2002
- Cerebrospinal fluid levels of nitric oxide metabolites predict response to methylprednisolone treatment in multiple sclerosis and optic neuritisJournal of Neuroimmunology, 2002
- Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosisZeitschrift für Neurologie, 2001
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Spinal cord atrophy and disability in multiple sclerosisBrain, 1996
- Insidious Atrophy of Retinal Nerve Fibers in Multiple SclerosisArchives of Ophthalmology (1950), 1974